SGX-listed glove makers nosedive on vaccine news, profit-taking
Singapore
SHARES of the trio of Singapore-listed glove names - Top Glove, Riverstone Holdings and UG Healthcare - skidded on Wednesday, shedding their gains from recent weeks, following news about Covid-19 vaccines in Russia, Singapore and the United States.
On Tuesday night, pharmaceutical firm Arcturus Therapeutics announced that Singapore's first volunteers have been dosed with a Covid-19 vaccine by Arcturus and Duke-NUS Medical School. Separately, Russia has approved its new vaccine against the novel coronavirus, while the US will buy 100 million doses of drugmaker Moderna's potential vaccine for some US$1.5 billion.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Google, US clash over search advertising as trial winds down
Apple rallies most in 18 months on upbeat forecast, buyback
US: Wall St opens sharply higher on soft jobs data
HSBC has no plans to dispose of further businesses, chairman says
Glencore Group nears deal for Shell’s Singapore oil refinery
Chinese share of French EV market slumps after incentives curbed